These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4912481)

  • 1. A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent.
    Choudhry AS; Gomez E; McKendry JB
    Appl Ther; 1970 May; 12(5):28-9. PubMed ID: 4912481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of diabetes mellitus with the E.R. 105 oral preparation].
    Domingo Gutiérrez AJ
    Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with a new antidiabetic: glybenclamide].
    Madsen SN; Persson I
    Ugeskr Laeger; 1970 Jan; 132(4):143-7. PubMed ID: 5442953
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
    Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
    Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
    [No Abstract]   [Full Text] [Related]  

  • 7. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
    Angeli G; Baraldi B; Tiraboschi L; Caputo G
    Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)].
    Schmitt H; Höhler H; Daweke H; Jahnke K
    Dtsch Med Wochenschr; 1969 Apr; 94(16):824-9. PubMed ID: 5776707
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial with HB 419 (Glybenclamide).
    Mitra PP
    Bull Calcutta Sch Trop Med; 1970 Jan; 18(1):13-5. PubMed ID: 5518463
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with glybenclamide in 100 non-ketotic diabetics.
    Sahgal VK; Ahuja MM
    Indian J Med Res; 1971 Feb; 59(2):251-8. PubMed ID: 4931412
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial of glycodiazine--a new oral hypoglycemic drug.
    Eisenberg S; Cohen AM
    Isr J Med Sci; 1966; 2(6):768-73. PubMed ID: 5334155
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with HB 419 (glybenclamide) in the ambulatory diabetes treatment].
    Stratmann FW
    Med Welt; 1969 Jun; 26():1489-92. PubMed ID: 5809503
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of tolazamide "'Tolanase') as an oral hypoglycaemic agent.
    Tewari SN; Fletcher R
    Br J Clin Pract; 1967 Sep; 21(9):455-6. PubMed ID: 4864489
    [No Abstract]   [Full Text] [Related]  

  • 16. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
    Balodimos MC; Marble A
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
    Belser F; Brögli H; Constam G; Zollikofer H
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences in the treatment of diabetics with the new oral hypoglycemic agent from the sulfonyl urea group].
    Durić DS; Popović S
    Med Glas; 1969; 23(5):92-7. PubMed ID: 4921012
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of glybenclamide, a hypoglycaemic agent.
    Walker RL
    Med J Aust; 1970 Nov; 2(22):1015-6. PubMed ID: 4924417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.